When the Brain Loses Touch With Reality

What psychosis is

A symptom, not a diagnosis

Psychosis describes a departure from shared reality — perceiving what is not there, or holding beliefs with certainty despite clear contrary evidence. It is not itself a diagnosis, and identifying it is the beginning of assessment rather than the end.

Its two best-known features are hallucinations and delusions. Hallucinations are sensory experiences without external source; hearing voices is most common, though any sense can be involved. Delusions are fixed beliefs that do not yield to evidence, frequently involving persecution, grandiosity, or the conviction that ordinary events carry particular personal significance.

Less recognized, and often more disabling over time, are the negative symptoms: reduced emotional expression, diminished speech, and loss of motivation. These are frequently mistaken for depression or for indifference, and they respond less readily to medication than hallucinations and delusions do.

Psychosis occurs across many conditions — in severe depression and bipolar disorder, with certain substances and medications, in some neurological and medical conditions, and following extreme sleep deprivation. Establishing which is operating determines everything that follows.

Schizophrenia

Among the most stigmatized diagnoses in medicine

Two corrections first, because both misconceptions are widespread. Schizophrenia does not mean split personality. And it does not mean violence — people with the condition are considerably more likely to be victims of it than perpetrators.

The condition involves positive symptoms — hallucinations, delusions, disorganized thinking — alongside negative symptoms that are less visible and frequently more limiting. Flattened expression, reduced motivation, diminished speech, and withdrawal are core features of the illness rather than signs of low effort or poor character, and they are routinely misread as both.

Onset is typically in late adolescence or early adulthood, somewhat earlier in men than women. Early intervention substantially improves the trajectory, which is why the delay between first symptoms and first treatment is among the most consequential variables in the whole picture.

Antipsychotic medication is the foundation of treatment. Psychological work, particularly involving family, has good evidence for reducing relapse and supporting functioning.

Schizophreniform disorder

The same picture, a shorter course

This carries the same symptom picture as schizophrenia, with an episode lasting between one and six months rather than the six months or longer required for that diagnosis.

The distinction matters because not everyone who experiences psychosis goes on to develop schizophrenia. Some have a single episode and recover completely. Others receive a revised diagnosis as the course becomes clearer. This is in part a diagnosis that allows a clinician to be accurate about what is known while remaining honest about what is not yet established.

Schizoaffective disorder

Psychosis alongside mood episodes

Here hallucinations or delusions occur together with significant mood episodes — depressive or manic — present for a substantial portion of the illness.

The defining feature is that psychotic symptoms persist during periods when mood symptoms are not active. That is what separates it from depression or bipolar disorder with psychotic features, where psychosis appears only within the mood episode. The distinction changes what treatment has to address, and it is frequently the point on which a diagnosis is revised.

Delusional disorder

Fixed belief without other features

This involves one or more persistent delusions without the hallucinations, disorganized thinking, or negative symptoms seen in schizophrenia. Outside the domain of the belief, functioning may appear entirely unremarkable — which is part of why it goes unrecognized for long periods.

The beliefs typically concern situations that could occur: being followed, being deceived by a partner, having an undetected illness, being loved by someone at a distance. Their plausibility is what makes them difficult to identify, and the conviction is generally absolute.

Brief psychotic disorder

Sudden onset, full recovery

Symptoms arrive abruptly and resolve within a month, followed by return to the previous level of functioning. It may follow a severe stressor — a death, a traumatic event, a major upheaval — or arrive without identifiable trigger.

The suddenness and intensity are frightening for everyone involved, and the prognosis is generally good. Hospitalization is sometimes needed during the acute phase for safety, and that fact does not alter the outlook.

Substance-induced psychosis

The distinction that changes the prognosis

Psychotic symptoms can arise during intoxication or withdrawal, or as a consequence of sustained use. Stimulants are the most common cause, and high-potency cannabis, hallucinogens, alcohol withdrawal, and a range of prescribed medications can all produce it. Sleep deprivation compounds every one of these.

The clinical question is whether the substance accounts for the presentation or has precipitated something that will continue without it. That question cannot be answered during acute intoxication, and it frequently cannot be answered in a single assessment. It generally requires observation across a period of abstinence, which is why an early diagnosis made in an emergency setting is sometimes revised later.

The distinction matters considerably, though it is not a clean division into resolving and persisting. Some substance-induced presentations resolve with sustained abstinence. Others persist, and in a meaningful proportion of cases the episode marks the beginning of a primary psychotic illness rather than a discrete effect of the substance — which is why the initial episode is followed rather than closed. Some people receive a schizophrenia diagnosis during a substance-related episode and carry it for years without reexamination; the reverse error, attributing a primary psychotic illness to substance use and delaying treatment on that basis, is at least as costly.

Two developments have made this harder to assess. Cannabis potency has increased substantially, so a person's own account of longstanding use may describe something materially different from what they are using now. And synthetic cannabinoids — laboratory-produced compounds sold as substitutes — are a separate class of drug, with potency that varies unpredictably between batches and psychotic presentations that are frequently more severe and more prolonged than cannabis produces. They also do not appear on standard toxicology, so a negative screen does not establish that nothing was taken. Assessment has to ask directly rather than rely on the panel.